Molecular Biology of Acyl-coenzyme A : cholesterol Acyltransferase
酰基辅酶 A 的分子生物学:胆固醇酰基转移酶
基本信息
- 批准号:08044304
- 负责人:
- 金额:$ 3.46万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We prepared a specific antiboty (DM10) against human acyl-conzyme A : cholesterol acyltransnferase (ACAT) and analyzed human tissues by immunohistochemical methods. ACAT was expressed in various human tissues including adrenal cortex, macrophages and their related cells such as Langerhans cells and alveolar macrophages, nervous cells such as Schwann cells and ganglion cells, and sebaceous glands. Under pathological conditions, ACAT was markedly expressed in aortic atherosclerotic lesions particularly in macrophage-derived foam cells, suggesting an important role of ACAT in atherogenesis. Western blotting of cultured human monocytics showed that expression of ACAT protein was markedly increased during monocyte differentiation, which explains, in part, marked expression of ACAT in human atherosclerotic lesions.We cloned rat ACAT cDNA as a homologue of human ACAT and examined its tissue distribution in rat. Among four tissues examined, ACAT activity was highest in adrenal followed by liver while those of intestine and aorta were low. The level of mRNA was also highest in adrenal. However, in contrast to high ACAT activity, the level of mRNA in liver was extremely low. Immunohistochemical staining with DM10 showed marked expression of ACAT in adrenal but negligible expression in liver. These results suggest the presence of ACAT isozyme in rat liver. Treatment of microsomal fraction of rat adrenal with chemical cross-linkers showed formation of dimer and tetramer of ACAT.Thus, we provided biochemical evidence for oligomerization of ACAT.
本文制备了抗人酰基辅酶A胆固醇酰基转移酶(ACAT)的特异性抗体(DM 10),并应用免疫组化方法对人体组织进行了分析。ACAT在各种人体组织中表达,包括肾上腺皮质、巨噬细胞及其相关细胞(如朗格汉斯细胞和肺泡巨噬细胞)、神经细胞(如许旺细胞和神经节细胞)和皮脂腺。在病理条件下,ACAT在主动脉粥样硬化病变中显著表达,尤其是在巨噬细胞源性泡沫细胞中,提示ACAT在动脉粥样硬化形成中的重要作用。Western blotting显示ACAT蛋白在单核细胞分化过程中表达显著增加,这部分解释了ACAT在动脉粥样硬化病变中的显著表达。在四种组织中,ACAT活性在肾上腺中最高,其次是肝脏,而肠和主动脉的活性较低。肾上腺中mRNA水平也最高。然而,与高ACAT活性相反,肝脏中的mRNA水平极低。免疫组织化学染色显示ACAT在肾上腺中有显著表达,但在肝脏中表达可忽略不计。提示大鼠肝脏中存在ACAT同工酶。用化学交联剂处理大鼠肾上腺微粒体组分,发现ACAT形成二聚体和四聚体,从而为ACAT的寡聚化提供了生化证据。
项目成果
期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakai, M., Miyazaki, A., Hakamata, H., Sato, Y., Matsumura, T., Kobiri, S., Shichiri, M., and Horiuchi, S.: "Lysophosphatidylcholline potentiates the mitogenic activity of modeified LDL for human monocyte-dirived macrophages." Arterioscler.Thromb.Vasc.Bio
Sakai, M.、Miyazaki, A.、Hakamata, H.、Sato, Y.、Matsumura, T.、Kobiri, S.、Shichiri, M. 和 Horiuchi, S.:“溶血磷脂酰胆碱增强修饰 LDL 的有丝分裂活性
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakai, M., Matsumura, T., Biwa, T., Hakamata, H., Ding, Y., Shichiri, M., and Horiuchi, S.: "Role of the macrophage scavenger receptor for internarization of lysophosphaticylcholine in oxidized low density lipoprotein-induced macdrophage growth." Ann.N.Y.
Sakai,M.,Matsumura,T.,Biwa,T.,Hakamata,H.,Ding,Y.,Shichiri,M.,and Horiuchi,S.:“巨噬细胞清道夫受体对氧化低溶血磷脂酰胆碱内化的作用
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakaguchi, H., Takeya, M., Suzuki, H., Hakamata, H., Kodama, T., Horiuchi, S., Gordon, S., van der Laan, L.J.W., Kraal, G., Ishibashi, S., Kitamura, H., and Takahashi, K.: "Role of macrophage scavengermreceptors in diet-induced atherosclerosis in mice." L
坂口 H.、竹谷 M.、铃木 H.、博又 H.、儿玉 T.、堀内 S.、戈登 S.、范德兰 L.J.W.、克拉尔 G.、石桥 S.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeshi Matsumura et al.: "Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low density lipoprotein-induced macrophage growth." Arteriosclerosis, Thrombosis, and Vascular Biology. 17. 3013-3020 (1997)
Takeshi Matsumura 等人:“蛋白激酶 C 激活的两条细胞内信号通路参与氧化低密度脂蛋白诱导的巨噬细胞生长。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakai, M., Miyazaki, A., Hakamata, H., Kodama, T., Suzuki, H., Kobori, S., Shichiri, M., and Horiuchi, S.: "the scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage prol
Sakai, M.、Miyazaki, A.、Hakamata, H.、Kodama, T.、Suzuki, H.、Kobori, S.、Shichiri, M. 和 Horiuchi, S.:“清道夫受体是
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORIUCHI Seikoh其他文献
HORIUCHI Seikoh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORIUCHI Seikoh', 18)}}的其他基金
Roles of CD36 and SR-BI as novel AGE-receptors
CD36 和 SR-BI 作为新型 AGE 受体的作用
- 批准号:
13470228 - 财政年份:2001
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AGE Structures and their Biomedical Significance
AGE 结构及其生物医学意义
- 批准号:
10044305 - 财政年份:1999
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Role of AGE Receptors in Diabetic Complications
AGE 受体在糖尿病并发症中的作用
- 批准号:
11557081 - 财政年份:1999
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Biological clearance system for advanced glycation end products (AGE) -Insulin signal regulates endocytic uptake of AGE-proteins
晚期糖基化终末产物 (AGE) 的生物清除系统 - 胰岛素信号调节 AGE 蛋白的内吞摄取
- 批准号:
09470225 - 财政年份:1997
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Detemination of The Main Advanced Glycation End Product of The Maillard Reaction and Its Significance as A Biochemical Marker for Diabetic Complications
美拉德反应主要高级糖基化终产物的测定及其作为糖尿病并发症生化标志物的意义
- 批准号:
07557076 - 财政年份:1995
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Structure and Function of Receptors for Advanced Glycation End Products of the Maillard Reaction
美拉德反应高级糖基化终产物受体的结构和功能
- 批准号:
06454170 - 财政年份:1994
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Non-enzymatic glycosylation of proteins in biological sytem and its physiological significance in aging process.
生物系统中蛋白质的非酶糖基化及其在衰老过程中的生理意义。
- 批准号:
62570136 - 财政年份:1987
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
ACAT-1介导胆固醇酯蓄积在宫颈癌细胞内的促癌机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
益肾清利活血方调控ACAT1乙酰化修饰TFEB修复自噬流改善肾纤维化的机制研究
- 批准号:82374373
- 批准年份:2023
- 资助金额:45 万元
- 项目类别:面上项目
ACAT1通过内质网-线粒体互作调控线粒体稳态在棕色脂肪细胞中的作用及机制研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
ACAT1作为CHK1抑制剂抗急性髓系白血病耐药生物标志物和联用靶点的探索性研究
- 批准号:82304539
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ACAT2/FASN/AcAc-CoA调控轴探讨促进脂肪酸合成代谢对抗血管内皮衰老的分子机制
- 批准号:n/a
- 批准年份:2023
- 资助金额:10.0 万元
- 项目类别:省市级项目
ACAT1通过溶酶体途径抑制脑出血后小胶质细胞持续吞噬能力的作用和机制研究
- 批准号:82371299
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
乳腺癌CDK4/6抑制剂耐药新机制:ACAT2代谢物Meta2靶向调控YAP构象及活性促进其核转位的机制研究
- 批准号:82303834
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AhR通过促进ACAT1转录介导肺癌细胞奥希替尼耐药的机制研究
- 批准号:2023JJ60078
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
代谢酶ACAT1核转位激活NF-κB发挥非经典生物学功能增强结直肠癌免疫治疗敏感性的机制研究
- 批准号:82303224
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACAT1蛋白第263位赖氨酸琥珀酰化在ARID1A突变型卵巢癌发生发展中的生物学功能及分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Regulation of ACAT in multiple risk factor syndrome
ACAT 在多危险因素综合征中的调节
- 批准号:
14571101 - 财政年份:2002
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of ACAT in diabetes and insuliln resistant
ACAT 在糖尿病和胰岛素抵抗中的调节
- 批准号:
12671118 - 财政年份:2000
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SYNTHESIS OF HELMINTHOSPOROL ANALOGS AS ACAT INHIBITORS
作为 ACAT 抑制剂的长蠕孢醇类似物的合成
- 批准号:
2881416 - 财政年份:1999
- 资助金额:
$ 3.46万 - 项目类别:
Synthesis of Helminthosporol Analogs as ACAT Inhibitors
作为 ACAT 抑制剂的长蠕孢醇类似物的合成
- 批准号:
6702528 - 财政年份:1999
- 资助金额:
$ 3.46万 - 项目类别:
Regulation of ACAT, an enzyme involved in cholesterol esterification and foam cell formation in vascular walls
ACAT(一种参与血管壁胆固醇酯化和泡沫细胞形成的酶)的调节
- 批准号:
10671077 - 财政年份:1998
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)